Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Jianpi Huayu Jiedu is a Traditional Chinese Medicine (TCM) herbal formula developed by the Affiliated Hospital of Nanjing University of Chinese Medicine. It is primarily investigated for its therapeutic potential in patients with colorectal cancer, specifically those exhibiting spleen deficiency syndrome following chemotherapy. The formula is designed to improve patient quality of life by modulating the intestinal microecology and enhancing immune function. Clinical research focuses on identifying key intestinal flora affected by the formula and clarifying the internal relationship between spleen deficiency and gut microbiota balance in the context of post-chemotherapy recovery.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Jianpi Huayu Jiedu.